急性卒中康复中机器人及常规补充步态训练的可行性与结局
这项评估者盲法随机对照试验在急性卒中住院康复中比较Lokomat®与常规步态训练作为补充治疗的可行性。
要点
- 急性卒中住院康复中,补充步态训练在常规治疗时间外可行且耐受良好。
- 常规组补充训练次数(12.8次)比Lokomat®组(8.9次)多约45%。
- 两组功能独立性评分改善均优于无补充治疗的参考组。
核心结论
- 在急性卒中住院康复中,经仔细规划,补充步态训练对日程干扰小且耐受良好,患者获得有意义的功能改善。
- Lokomat®与常规步态训练的方法间总体比较偏向Lokomat®组有差异获益但未达显著,效应量为中等。
研究设计与样本
- 评估者盲法随机对照试验,在三级住院康复机构开展。
主要发现
- 补充治疗在正常护理交付时段内实施,患者一般耐受良好。
- 两组在多项指标上均明显改善,常规步态训练组获得的补充训练次数(12.8次)比Lokomat®组(8.9次)多近45%。
- 两组功能独立性量表运动评分改善值(出院减入院)均大于无补充治疗的参考组。
- 观察显示机器人组平均完成更多步数。
关键数值与推荐
- 下肢MAS≤3作为纳入标准。
- 常规组补充训练12.8次,Lokomat®组8.9次,常规组约多45%。
- 方法间总体比较未达显著,Lokomat®组效应量为中等。
临床怎么用
- 急性卒中住院康复期可考虑在常规治疗外安排补充步态训练,需仔细规划以减少对日程的干扰。
- 选择Lokomat®或常规步态训练均可作为补充手段,前者可能以更少次数提供更优治疗剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Practicality of implementation and dosing of supplemental gait training in an acute stroke inpatient rehabilitation setting are not well studied but can have positive impact on outcomes. OBJECTIVES: To determine the feasibility of early, intense supplemental gait training in inpatient stroke rehabilitation, compare functional outcomes and the specific mode of delivery. DESIGN AND SETTING: Assessor blinded, randomized controlled trial in a tertiary Inpatient Rehabilitation Facility. PARTICIPANTS: Thirty acute post-stroke patients with unilateral hemiparesis (≥ 18 years of age with a lower limb MAS ≤ 3). INTERVENTION: Lokomat® or conventional gait training (CGT) in addition to standard mandated therapy time. MAIN OUTCOME MEASURES: Number of therapy sessions; adverse events; functional independence measure (FIM motor); functional ambulation category (FAC); passive range of motion (PROM); modified Ashworth scale (MAS); 5 times sit-to-stand (5x-STS); 10-m walk test (10MWT); 2-min walk test (2MWT) were assessed before (pre) and after training (post). RESULTS: The desired supplemental therapy was implemented during normal care delivery hours and the patients generally tolerated the sessions well. Both groups improved markedly on several measures; the CGT group obtained nearly 45% more supplemental sessions (12.8) than the Lokomat® group (8.9). Both groups showed greater FIM improvement scores (discharge - admission) than those from a reference group receiving no supplemental therapy. An overarching statistical comparison between methods was skewed towards a differential benefit (but not significant) in the Lokomat® group with medium effect sizes. By observation, the robotic group completed a greater number of steps, on average. These results provide some evidence for Lokomat® being a more efficient tool for gait retraining by providing a more optimal therapy "dose". CONCLUSIONS: With careful planning, supplemental therapy was possible with minimal intrusion to schedules and was well tolerated. Participants showed meaningful functional improvement with relatively little supplemental therapy over a relatively short time in study.
引用
- Talaty M, Esquenazi A. Feasibility and outcomes of supplemental gait training by robotic and conventional means in acute stroke rehabilitation. J Neuroeng Rehabil. 2023. PMID: 37794474. doi:10.1186/s12984-023-01243-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。